Literature DB >> 17988893

Rates of brain atrophy over time in autopsy-proven frontotemporal dementia and Alzheimer disease.

Jennifer L Whitwell1, Clifford R Jack, V Shane Pankratz, Joseph E Parisi, David S Knopman, Bradley F Boeve, Ronald C Petersen, Dennis W Dickson, Keith A Josephs.   

Abstract

Rates of brain loss have been shown to accelerate over time in early Alzheimer disease (AD); however the trajectory of change in frontotemporal lobar degeneration with ubiquitin immunoreactive-changes (FTLD-U) is unknown. This study compared the progression of atrophy over multiple MRI in subjects with autopsy-confirmed AD and FTLD-U. Nine subjects with autopsy-confirmed FTLD-U and nine with autopsy-confirmed AD were identified that had three or more serial MRI. The boundary-shift integral was used to calculate change over time in whole-brain and ventricular volume. A hierarchical regression model was used to estimate the slope of volume change in AD and FTLD-U over time and to estimate differences in the slopes across the subject groups. Whole-brain volume loss did not deviate from a linear rate over time in both AD and FTLD-U subjects, although this may be due to limited sample size. The FTLD-U subjects had a faster rate (23 ml/year) than the AD subjects (10 ml/year). The rate of ventricular expansion accelerated over time. At the point when each subject had a Clinical Dementia Rating Sum-of-Boxes score of 6, the annual rate was 7 ml/year in FTLD-U and 5 ml/year in AD. These rates of change increased by an estimated 1.66 ml/year in FTLD-U and 0.44 ml/year in AD, although these estimates were not significantly different between the two groups. The trajectories of brain and ventricular changes were similar in AD and FTLD-U suggesting that it is independent of pathology, although subjects with FTLD-U show a more rapidly progressive decline.

Entities:  

Mesh:

Year:  2007        PMID: 17988893      PMCID: PMC2268641          DOI: 10.1016/j.neuroimage.2007.10.001

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  29 in total

1.  Staging disease severity in pathologically confirmed cases of frontotemporal dementia.

Authors:  M Broe; J R Hodges; E Schofield; C E Shepherd; J J Kril; G M Halliday
Journal:  Neurology       Date:  2003-03-25       Impact factor: 9.910

2.  MRI as a biomarker of disease progression in a therapeutic trial of milameline for AD.

Authors:  C R Jack; M Slomkowski; S Gracon; T M Hoover; J P Felmlee; K Stewart; Y Xu; M Shiung; P C O'Brien; R Cha; D Knopman; R C Petersen
Journal:  Neurology       Date:  2003-01-28       Impact factor: 9.910

3.  The MRI pattern of frontal and temporal brain atrophy in fronto-temporal dementia.

Authors:  Marina Boccardi; Mikko P Laakso; Lorena Bresciani; Samantha Galluzzi; Cristina Geroldi; Alberto Beltramello; Hilkka Soininen; Giovanni B Frisoni
Journal:  Neurobiol Aging       Date:  2003 Jan-Feb       Impact factor: 4.673

4.  Frontotemporal lobar degeneration and ubiquitin immunohistochemistry.

Authors:  K A Josephs; J L Holton; M N Rossor; A K Godbolt; T Ozawa; K Strand; N Khan; S Al-Sarraj; T Revesz
Journal:  Neuropathol Appl Neurobiol       Date:  2004-08       Impact factor: 8.090

5.  Normalization of cerebral volumes by use of intracranial volume: implications for longitudinal quantitative MR imaging.

Authors:  J L Whitwell; W R Crum; H C Watt; N C Fox
Journal:  AJNR Am J Neuroradiol       Date:  2001-09       Impact factor: 3.825

6.  Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease.

Authors:  G M McKhann; M S Albert; M Grossman; B Miller; D Dickson; J Q Trojanowski
Journal:  Arch Neurol       Date:  2001-11

7.  MR image-based measurement of rates of change in volumes of brain structures. Part II: application to a study of Alzheimer's disease and normal aging.

Authors:  Deming Wang; Jonathan B Chalk; Stephen E Rose; Greig de Zubicaray; Gary Cowin; Graham J Galloway; Daniel Barnes; Donna Spooner; David M Doddrell; James Semple
Journal:  Magn Reson Imaging       Date:  2002-01       Impact factor: 2.546

8.  Methodological considerations for measuring rates of brain atrophy.

Authors:  Jeffrey L Gunter; Maria M Shiung; Armando Manduca; Clifford R Jack
Journal:  J Magn Reson Imaging       Date:  2003-07       Impact factor: 4.813

9.  Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD.

Authors:  C R Jack; M M Shiung; J L Gunter; P C O'Brien; S D Weigand; D S Knopman; B F Boeve; R J Ivnik; G E Smith; R H Cha; E G Tangalos; R C Petersen
Journal:  Neurology       Date:  2004-02-24       Impact factor: 9.910

10.  Change in rates of cerebral atrophy over time in early-onset Alzheimer's disease: longitudinal MRI study.

Authors:  Dennis Chan; John C Janssen; Jennifer L Whitwell; Hilary C Watt; Rhian Jenkins; Chris Frost; Martin N Rossor; Nick C Fox
Journal:  Lancet       Date:  2003-10-04       Impact factor: 79.321

View more
  23 in total

1.  Modeling and Estimating Recall Processing Capacity: Sensitivity and Diagnostic Utility in Application to Mild Cognitive Impairment.

Authors:  Michael K Wenger; Selamawit Negash; Ronald C Petersen; Lyndsay Petersen
Journal:  J Math Psychol       Date:  2010-02-01       Impact factor: 2.223

2.  Longitudinal MRI atrophy biomarkers: relationship to conversion in the ADNI cohort.

Authors:  Shannon L Risacher; Li Shen; John D West; Sungeun Kim; Brenna C McDonald; Laurel A Beckett; Danielle J Harvey; Clifford R Jack; Michael W Weiner; Andrew J Saykin
Journal:  Neurobiol Aging       Date:  2010-08       Impact factor: 4.673

3.  Sparse unbiased analysis of anatomical variance in longitudinal imaging.

Authors:  Brian Avants; Philip A Cook; Corey McMillan; Murray Grossman; Nicholas J Tustison; Yuanjie Zheng; James C Gee
Journal:  Med Image Comput Comput Assist Interv       Date:  2010

Review 4.  Progression of atrophy in Alzheimer's disease and related disorders.

Authors:  Jennifer L Whitwell
Journal:  Neurotox Res       Date:  2010-03-30       Impact factor: 3.911

5.  Predicting functional decline in behavioural variant frontotemporal dementia.

Authors:  Keith A Josephs; Jennifer L Whitwell; Stephen D Weigand; Matthew L Senjem; Bradley F Boeve; David S Knopman; Glenn E Smith; Robert J Ivnik; Clifford R Jack; Ronald C Petersen
Journal:  Brain       Date:  2011-01-20       Impact factor: 13.501

6.  Distinct cerebral perfusion patterns in FTLD and AD.

Authors:  W T Hu; Z Wang; V M-Y Lee; J Q Trojanowski; J A Detre; M Grossman
Journal:  Neurology       Date:  2010-09-07       Impact factor: 9.910

7.  Dementia induces correlated reductions in white matter integrity and cortical thickness: a multivariate neuroimaging study with sparse canonical correlation analysis.

Authors:  Brian B Avants; Philip A Cook; Lyle Ungar; James C Gee; Murray Grossman
Journal:  Neuroimage       Date:  2010-01-18       Impact factor: 6.556

8.  Longitudinal rates of lobar atrophy in frontotemporal dementia, semantic dementia, and Alzheimer's disease.

Authors:  Casey E Krueger; David L Dean; Howard J Rosen; Cathra Halabi; Michael Weiner; Bruce L Miller; Joel H Kramer
Journal:  Alzheimer Dis Assoc Disord       Date:  2010 Jan-Mar       Impact factor: 2.703

9.  Brain and ventricular volumetric changes in frontotemporal lobar degeneration over 1 year.

Authors:  D S Knopman; C R Jack; J H Kramer; B F Boeve; R J Caselli; N R Graff-Radford; M F Mendez; B L Miller; N D Mercaldo
Journal:  Neurology       Date:  2009-05-26       Impact factor: 9.910

10.  Analysis of alternative splicing associated with aging and neurodegeneration in the human brain.

Authors:  James R Tollervey; Zhen Wang; Tibor Hortobágyi; Joshua T Witten; Kathi Zarnack; Melis Kayikci; Tyson A Clark; Anthony C Schweitzer; Gregor Rot; Tomaž Curk; Blaž Zupan; Boris Rogelj; Christopher E Shaw; Jernej Ule
Journal:  Genome Res       Date:  2011-08-16       Impact factor: 9.043

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.